Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?
Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive years.
Search results for "operating profit"
From 8.7 Billion Deficit to 16.3 Billion Surplus: Seers Strikes Gold in the Middle East
"We have been working to penetrate the Middle Eastern market since 2018. The pricing per bed and equipment costs there are 3 to 10 times higher than...
Samsung Bioepis Achieves Record Sales of 1.672 Trillion Won Last Year
Samsung Bioepis achieved its highest performance last year in terms of sales. Excluding short-term milestone revenues,...
Celltrion Opens Production Facility in New Jersey Acquired from Eli Lilly
On the 5th , Celltrion announced on the 6th that it held an opening ceremony at its production facility located in...